Ann: Compelling Preclinical Breast Cancer Results, page-135

Really you should do more research - you’ll have less stress , and posture less , and be more confident with your decisions .

Sorry to hear you sold out when you did .
It definitely isn’t too late however - one of my family members bought for the first time ... finally! , yesterday . ( I had talked of intermittently for well over 12 months ) They bought the open & I thought they could have done a bit better yesterday, but a 5 or 10c difference buy is absolutely of no consequence now with RAC . Just best to be aboard.
Thank goodness now.

The shares in RAC are tightly held .
The calibre of the entire management team and scientific team , with the value of this incredible asset ; + shareholder register & low SOI .
Management not on exorbitant salaries - all have bought and own significant shares . Etc .
In addition to the information and significant proving of , as well as newer targeted abilities likely with Bisantrene.
note - all cancers are now more routinely being ‘typed ’ , and genetic or important factors with each persons individual cancer being identified for individual targeted cancer treatments as well with treatment planning , ultimately for all .

RAC - the potentials and opportunity here is real .